Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patientsSharon A. Glynn, Stefan Ambs, Harris G. Yfantis et al.|Journal of Clinical Investigation|2010Cited by 250
Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt ActivationLisa A. Ridnour, David A. Wink, Kimberly M. Barasch et al.|PLoS ONE|2012Cited by 71